1-2 of 2
Pinuccia Valagussa, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Trial of Combination of the Histone Deacetylase Inhibitor ITF2357 and Meclorethamine Demonstrates Clinical Activity and Safety in Heavily Pretreated Patients with Relapsed/Refractory Hodgkin Lymphoma (HL)

Carmelo Carlo-Stella, MD, Anna Guidetti, MD, Simonetta Viviani, MD, Valeria Bonfante, MD, Pinuccia Valagussa, MD, Alfonso Marchianò, MD, Flavio Crippa, MD, Stefania Zambelli, MD, Cinzia Fasola, MD, Paolo Corradini, MD, Corrado Tarella, MD, Massimo Di Nicola, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2008) 112 (11): 2586.
https://doi.org/10.1182/blood.V112.11.2586.2586
Published: 2008
Journal Articles

Reduced-Intensity Conditioning (RIC) Followed by Allogeneic Stem Cell Transplantation (SCT) for Relapsed Lymphomas: Impact of Pre-Transplantation Factors on Long-Term Outcome.

Paolo Corradini, MD, Anna Dodero, MD, Marco Bregni, MD, Fabio Ciceri, MD, Attilio Olivieri, MD, Lucia Farina, MD, Pinuccia Valagussa, MD, Rosanna Scime’, MD, Anna Locasciulli, MD, Francesca Patriarca, MD, Alessandro Massimo Gianni, MD, Corrado Tarella, MD
Journal: Blood
Blood (2005) 106 (11): 1129.
https://doi.org/10.1182/blood.V106.11.1129.1129
Published: 2005